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Abstract
Background: Partial loss of function of the transcription factor FOXL2 leads to premature ovarian
failure in women. In animal models, Foxl2 is required for maintenance, and possibly induction, of
female sex determination independently of other critical genes, e.g., Rspo1. Here we report
expression profiling of mouse ovaries that lack Foxl2 alone or in combination with Wnt4 or Kit/c-Kit.
Results: Following Foxl2 loss, early testis genes (including Inhbb, Dhh, and Sox9) and several novel
ovarian genes were consistently dysregulated during embryonic development. In the absence of
Foxl2, expression changes affecting a large fraction of pathways were opposite those observed in
Wnt4-null ovaries, reinforcing the notion that these genes have complementary actions in ovary
development. Loss of one copy of Foxl2 revealed strong gene dosage sensitivity, with molecular
anomalies that were milder but resembled ovaries lacking both Foxl2 alleles. Furthermore, a Foxl2
transgene disrupted embryonic testis differentiation and increased the levels of key female markers.
Conclusion: The results, including a comprehensive principal component analysis, 1) support the
proposal of dose-dependent Foxl2 function and anti-testis action throughout ovary differentiation;
and 2) identify candidate genes for roles in sex determination independent of FOXL2 (e.g., the
transcription factors IRX3 and ZBTB7C) and in the generation of the ovarian reserve downstream
of FOXL2 (e.g., the cadherin-domain protein CLSTN2 and the sphingomyelin synthase SGMS2). The
gene inventory is a first step toward the identification of the full range of pathways with partly
autonomous roles in ovary development, and thus provides a framework to analyze the genetic
bases of female fertility.
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Background
Menopause, one of the most clear-cut features of female
mammalian aging, ensues when the ovarian follicle pool
is depleted [1-3]. Hormonal regulation of ovulation from
antral follicles is well studied, and many gene mutations
and disruptive agents are known to affect oocyte quality
and quantity at defined stages of ovary development and
maturation. However, the formation and maintenance of
the follicle reserve have remained less defined [4-9]. Sim-
ilarly unclear is the mechanism that connects follicle for-
mation – perhaps the most critical stage of ovary
differentiation – to sex determination, the process
whereby the sexually bipotential gonad forms either a tes-
tis or an ovary [5,10-17].
Acting with the master regulator SRY, a large number of
genes are currently known to drive testis differentiation in
mammals (e.g., [18]). By contrast, although several potent
regulatory genes that act in early ovary development have
been identified – including those encoding the secreted
proteins WNT4 and RSPO1, and the transcription factors,
DAX1/NR0B1 and FOXL2 – their relation to now classical
hypotheses about the genetic basis of female sex determi-
nantion in mammals [19,20] is still debated, and their
mechanism of action is controversial ([17,21-24], and ref-
erences therein). One striking distinction among them is
that the other "early ovarian" genes are mainly expressed
in somatic cells of the bipotential gonad in both sexes; but
Foxl2 is only expressed in females. Furthermore, muta-
tions in Foxl2 are notably involved in three well-defined
conditions that cover the entire spectrum of ovarian
pathology: premature ovarian failure with and without
ovarian dysgenesis in humans [25]; blockage of follicle
formation with secondary partial ovary-to-testis sex
reversal in mice [14,26]; and embryonic sex reversal,
sometimes leading to complete XX maleness in goats [27].
We have further shown that in mice the combined loss of
Foxl2 and Wnt4 leads to extensive gonadal XX sex reversal
involving all cell lineages [17]. A similar degree of sex
reversal was recently obtained in a mouse knockout
model for Rspo1 [21]. In humans, RSPO1 is the only ovar-
ian gene known to be associated with complete XX sex
reversal [28], and in mice, it is at least partly required for
Wnt4  expression [21]. In fact, Foxl2  and  Rspo1  are
expressed independently of one another throughout fetal
life [17,21-23]. Thus, Foxl2  and Rspo1  regulate distinct
female sex determining pathways and redundantly antag-
onize the action of testis determinants such as the tran-
scription factor SOX9.
Like its regulatory gene Rspo1 [21], Wnt4 activation in the
embryonic ovary is also independent of Foxl2 throughout
mouse fetal life ([17] and this study). This indicates that
studies of Wnt4 and Foxl2 can provide important comple-
mentary information about female sex determination and
early ovary differentiation. We have compared ovarian
transcriptomes of wild-type mice with mice lacking Wnt4,
Foxl2, or both in the context of comparative analyses of all
available microarray datasets for gonadal development
and maturation. The results point toward highly specific
candidate genes involved in gonadal sexual dimorphism,
ovary aging, or both. The putative gene targets were in
general consistent with further ovarian transcriptome
analyses of ovaries deficient in oocytes (Kit/c-kit Wv/Wv),
and were validated by corresponding changes in their
expression in mouse embryos overexpressing transgenic
Foxl2.
Results
1. Overview of gonadal development and maturation by 
principal component analysis: convergence of the 
maturing ovary to a testis-like profile
To focus on ovary maturation and aging in relation to
gonadal development, we compared comprehensive gene
expression profiles among a set of 141 microarray
gonadal samples, of which 43 come from our study and
98 were reanalyzed from public databases deposited by 4
other laboratories in addition to ours (see Methods and
below, section 2). The samples spanned the life history of
the mouse ovary and testis from the bipotential gonad to
adulthood, including several mouse models of premature
ovarian failure. In order to identify major expression pro-
files associated with distinct genotypes and developmen-
tal stages, we used principal component analysis (PCA),
an unsupervised clustering method that does not rely on
a priori class assignment. Essentially, the method first
identifies the group of genes with correlated expression
profiles that account for the greatest amount of variance in
the dataset (the first principal component, PC1), and then
sequentially looks for additional co-expression profiles
that are not correlated with the first group and account for
decreasing amounts of variance (see Methods).
In Figure 1A, two distinct groups of correlated profiles,
represented by the first two principal components (PC1
and PC2), robustly discriminated gonadal samples into
appropriate clusters of biological replicates, placing all
testis (diamond) and ovary (circle) samples in trajectories
according to developmental stages (details about the sam-
ples are given in additional files 1A–B and 2A). In Figure
1B, colored symbols are added to show the relative posi-
tions of clusters at specific times when particular genes of
importance were ablated singly or in combination. The
300 most variable genes were sufficient for good discrim-
ination, but better resolution was obtained with longer
lists, i.e., about 6,000 top-ranking markers (Figure 1 and
see additional file 2A).
PC1, the first principal component, i.e., the horizontal
axis of Figure 1, represented ~40% of the total variance of
the developmental gonadal marker genes. In the bipoten-BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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tial gonad, at E10–E12, as expected, sets of genes were
close by in ovary and testis. Then, along PC1, developing
ovaries first diverged sharply from embryonic testes and
subsequently moved back to values that were increasingly
similar to newborn testes (E18 to adult ovary, as labeled
at the top of Figure 1A). The trend is thus in keeping with
morphological indications that some features of follicle
maturation involve testis differentiation-like processes
(see [16] for a recent review).
The genes that showed sharp timing differences in their
levels of expression along PC1 (see Methods) included
those involved in meiotic activity as well as other early
ovary somatic cell markers (e.g., Irx3, Fst, and Dmc1h) that
had maximum values at the left of the PC1 axis. In addi-
tion, many top-scoring genes were involved in steroido-
genesis and other early features of testis somatic cell
differentiation (e.g., Dhh, Cyp17a1 and Cyp11a1), with
maximum values at the right of the PC1 axis (Figure 1A
and see additional file 2B). Furthermore, their PC1 posi-
tions in Figure 1B illustrate that Wnt4-/- ovaries and, to a
lesser extent, Foxl2-/-, KitWv/Wv and Lhx8-/- ovaries, mapped
consistently closer to testis than did age-matched wild-
type control ovaries. Also, double mutants showed addi-
tive or synergistic effects on "movement toward testis".
However, the relative contribution of reduced meiotic
activity vs increased activity of steroidogenic genes and/or
testis-like programs appears to differ in each type of
mutant. Indeed, newborn ovaries lacking Kit, Lhx8 or
Wnt4 lie relatively close together along PC1 in spite of
their very different composition in germ cell numbers and
their highly divergent degrees of sex reversal (see below).
Consistent with distinct roles of meiotic and testis genes
along the PC1 axis, an adult, germ cell-depleted, Kitl-defi-
cient testis sample mapped at the far right of the graph
(Figure 2B), i.e., nearer newborn testes than adult wild-
type testes (the latter are located in the middle of the
graph). Thus, multiple pathways, ranging from control of
meiosis to somatic cell sex reversal, are involved in PC1.
In the case of the second axis (PC2) as well, multiple dis-
tinct pathways may be involved, but because they appear
dissociated by PCA, they are likely different and relatively
autonomous from those accounting for PC1. Of interest,
PC2 pointed toward many genes involved in follicle for-
mation. For example, newborn ovaries, which are
enriched in primordial follicles (e.g., [1,2]), were remark-
ably clustered at the top of PC2, and several genes
involved in early follicle development, i.e., Lhx8, Figla,
and Sohlh1 (cf. [6]) strongly correlated with this axis (see
additional file 2C). However, follicle formation is only
part of the underpinning of PC2, because some newborn
ovary samples (e.g., Kit mutants) were also high-scoring
even though they are known to be largely devoid of folli-
cles.
Overall, a representative "gonadal developmental tran-
scriptome", trained on pre- and neonatal gonadal samples
by PCA, appears to discriminate the range of wild-type
gonadal variation throughout life. In addition, PCA sug-
gests that dysgenetic ovaries activate programs that may
represent the anticipation of a normal maturation/aging
process and which may be a causative factor for associated
pathology. However, PCA does not discriminate between
possible different contributions to this aging-like process,
First two principal components of PCA trained on the  expression profiles of 6,455 developmental marker genes Figure 1
First two principal components of PCA trained on 
the expression profiles of 6,455 developmental 
marker genes. Several published gonadal microarray data-
sets ("test dataset") have then been mapped onto the PCA 
space (our large panel of wild-type and mutant gonads) (x-
axis, PC1; y-axis, PC2; PC units, linear transformations of the 
rank-normalized gene expression intensities). A) Illustration 
of the trajectories (arrow-headed lines) corresponding to 
normal gonadal development in females (circles) and males 
(diamonds). B) Trajectories of mutant gonads (colored 
shapes) added to the wild-type panel (i.e., as in A; arrows 
have the same colors as the corresponding samples).
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in particular the effects of meiotic germ cell depletion vs.
the activation of bona fide testis-like pathways in somatic
cells. In addition, the expression profiles of some genes
with important gonadal functions, including Foxl2 and
Sox9 (see below), correlated only weakly with PCA coor-
dinates. In particular, they both ranked > 100th among
genes that were ordered according to their degree of corre-
lation with PC1 using the Focus classifier (see additional
file 2C; consistent results were obtained with "predictive
analysis of microarray", PAM [29], data not shown). We
infer that functional studies of ovary development and
maturation may be more incisive if one includes system-
atic comparisons to testis samples in appropriately chosen
developmental models. We thus present the molecular
characterization of Foxl2-null ovaries in the context of
other models of ovarian dysgenesis, with special emphasis
on the comparison of wild-type ovary and testis differen-
tiation.
2.1. Foxl2 knockout ovaries
Foxl2-/-  knockout ovaries have a histomorphologically
normal appearance before birth. To detect molecular
Real-time PCR data for fetal and newborn gonads of all relevant genotypes Figure 2
Real-time PCR data for fetal and newborn gonads of all relevant genotypes. Top: Ovarian genes that require Foxl2; 
Middle: Testis genes that are derepressed in the absence of Foxl2; Bottom: Ovarian genes that are independent of Foxl2. Note 
that several of these genes are differentially regulated in Foxl2-null ovaries aged 13.5 dpc. Arrows indicate the relevant changes 
in expression levels between neighboring conditions (unexplained change involving Inhbb as discussed in the text: dotted 
arrow). For each gene, normalized expression intensities (y-axis) are represented as a fraction of the maximum mean value 
observed (the latter being set to 100). The x-axis indicates the genotype and stage (E stands for "days post coitum" and P0 for 
birth, "0 days post natum").
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changes that may nonetheless predate postnatal anoma-
lies, we sampled ovaries from prenatal and neonatal
stages (13.5 and 16.5 days postcoitum, dpc, and birth).
These sampling times covered the period of greatest varia-
tion in gonadal developmental genes (Figure 1A, above)
and could minimize minor stage-specific changes or small
shifts in developmental rate that might bias single time
points with age-matched samples. To this end, linear con-
trasts implemented in the Focus software work well [30]:
the 20 top-ranking differentially expressed genes (up or
down) are listed in the left column of Table 1, and the full
lists are given in additional files 3A–B. We also obtained a
combined gene list from standard pair-wise analyses,
which was highly consistent but much less sensitive (see
additional file 3C and Methods). In addition, we sampled
for comparison Wnt4-null ovaries at 15.5 dpc, i.e., the
stage at which partial sex reversal is well started but
oocytes are still present and well differentiated.
We first adopted a strategy to identify highly specific
(though possibly indirect) targets of Foxl2, as follows.
2.2. Candidate genes for a primary role downstream of Foxl2: 
profiling of compound knockout models involving Foxl2
We reasoned that primary targets of Foxl2 would tend to
be differentially expressed in all ovaries lacking Foxl2
either alone (from the above analysis) or in combination
with the ablation of Wnt4 or Kit. At birth, these various
mouse models show very different morphology, cell com-
position, and endocrine function, and may thus provide a
stringent framework for the identification of Foxl2-
dependent genes [17]. We compiled lists for genes that
were differentially expressed in Wnt4-/-Foxl2-/- and  Kit-/-
Foxl2-/- double knockout ovaries relative to ovaries lacking
Wnt4 or Kit  function but harboring a functional Foxl2
allele (see additional file 4A–B, the 20 top genes up- and
down-regulated are given in Table 1). We then intersected
these lists with lists of genes associated with loss of Foxl2
alone (see above). That list comprises 190 and 78 genes
that were systematically down or up-regulated in the
absence of Foxl2 (see additional file 4C; the 20 top genes
up and down are given in Table 1, second column from
right). These lists thus include highly specific genes that
may mediate Foxl2 action, as follows.
Inspection of the top genes in the lists (Table 1) indicates
that a large fraction of Foxl2-dependent genes have no pre-
viously assigned role in gonadal development but have
been associated with either neuronal or vascular develop-
ment (as indicated by asterisk or underline, respectvely, in
Table 1, column 3 from the left). Some show female-spe-
cific upregulation in supporting or steroidogenic cells of
embryonic gonads, including a transcription factor,
ODZ4, and several plasma transmembrane proteins,
including plexin (PLXNC1), the cadherin-domain con-
taining Calsyntenin 2 (CLSTN2), and a leucine-rich repeat
protein (LRRC4) (bold font, Table 1). Because some of
these genes are involved in brain cortical patterning
[31,32], they might conceivably mediate the formation of
the ovarian cortico-medullary axis, which is essential for
follicle dynamics and reproductive longevity in mam-
mals, and has no histoanatomical counterpart in the testis
[33].
Top-ranking down-regulated genes also included Grip1
(glutamate receptor interacting protein 1), a nuclear
repressor required for estrogen receptor alpha activity, and
the gene encoding the AKR1C14 aldo-keto reductase,
which can metabolize the most potent natural androgen,
dihydrotestosterone [34,35]. Foxl2-dependence of these
genes during embryonic development (Figure 2) might
reflect an early role for Foxl2 in regulating sex-specific ster-
oidogenesis, which may be particularly important in
higher mammals. Furthermore, starting around 16.5 dpc,
upregulation of aromatase/Cyp19a1  and the nuclear
receptor Nr5a2/LRH-1, related to the master regulator of
steroidogenesis, Nr5a1/Steroidogenic factor-1, was strongly
reduced in Foxl2-null ovaries relative to controls.
Additional hits further down the lists included sphingo-
myelin synthase Sgms2 (see additional file 4C). It may be
a positive regulator of primordial follicle formation and/
or maintenance, given that loss of a sphingomyelinase,
which performs the reverse metabolic reaction, was
reported to enhance primordial follicle maintenance in
mice [36]. Another hit, encoding the cytoskeletal protein
BICD1 that is related to a maternal fertility factor in Dro-
sophila, was enriched in primordial follicles of both
oocytes and somatic cells (data from [37,38]). It may
complement the action of a paralogue, BICD2, that we
have previously shown to be expressed in growing oocytes
[39].
Expression levels were sometimes altered starting from
13.5 dpc, as validated by real-time PCR (Figure 2). There
the levels in E13 testis, first three bars at the left of each
row, are compared to levels in the ovary collected at vari-
ous developmental stages in wild-type and mutant mice;
the corresponding microarray data (see additional file 5)
are concordant in every case. Their relevance as candidate
Foxl2 targets was further substantiated by experiments in
which an added Foxl2 transgene was provided to wild-type
mice (see below).
The comparison of ovaries lacking Foxl2 alone or in com-
bination with either of two other genes therefore priori-
tizes candidate target genes that show sensitivity to Foxl2
loss in the independent mouse models. Candidate Foxl2
targets may also be inferred by their response to multiple
ovarian regulatory pathways, as follows.BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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2.3. Candidate Foxl2 target genes that respond to Wnt4 or other 
ovarian pathways
We cross-compared all mouse models of ovarian dysgen-
esis that have been studied by microarray expression pro-
filing to date. They include knockouts of the somatic
genes Emx2 and Wnt4, and the oocyte genes Lhx8, Nobox,
Foxo3 and Figla1 [40-46]. We reanalyzed the respective
datasets compared to their respective controls (see Meth-
ods and additional files 6A–J). As expected for genes that
are all required for fetal and newborn ovary development,
the resulting lists of differentially expressed genes indi-
cated similar alterations, reflecting synergistic effects. In
particular, several well-known ovarian markers were com-
parably changed. Inferred putative interactions are repre-
Table 1: Foxl2-null ("KO") ovaries relative to wild-type and in various biological contexts.
A. Down in Foxl2 KO (induced by Foxl2)
rank Single Foxl2 KO Compound Foxl2 KOs Single Foxl2 KO and compound Foxl2 KO Foxl2 single KO and Wnt4 single KO
1 (Foxl2) (Foxl2) (Foxl2) (Foxl2)
2 Thbs2 Nupr1 Ntn4 Thbs2
3 Peg10 Thbs1 Thbs1 Kitl
4 Sdc4 Ephx2 Adamts16 Gstm1
5 Fbn2 1810010m01rik/ZG-16p Col8a1 Cpa2
6 9630031f12rik Loc640441 Clstn2* Il13ra2
7 Akr1c14 Cyp19a1/aromatase Cpa2 ENSMUSG00000069372
8 Ntn4 Dppa3 Smad3 Peg10
9 Cdkn1b Myo1b Slc26a7 Tnfrsf19
10 Thbs1 Ramp1 Chst9 9630031F12Rik
11 E330037m01rik Slc26a7 Loc640441 Micalcl
12 Col8a1 Col8a1 Lrrc4* Dync1i1
13 Adamts16 Plxnc1* Bcat1 Fbn2
14 Serpine2 Ntn4 Itga6 Gpc4
15 Clstn2* Clstn2* Il13ra2 Gstm7
16 Grip1 Odz4* Nupr1 Fbn2
17 Speer4b Apoa1 Plxnc1* Upk2
18 Rgs2 Bcat1 Angptl6 Cdkn1b
19 Cpa2 Lrrc4* Chn2 Akr1c14
20 Lmo3 Pdpn Odz4* Tmem20
B. Up in Foxl2 KO (repressed by, or competitive with Foxl2)
rank Single Foxl2 KO Compound Foxl2 KOs Single Foxl2 KO and compound Foxl2 KO Foxl2 single KO and Wnt4 single KO
1 Jakmip1 Tesc Adamts8 Inhbb
2 Slc8a3 Pnmt Hsd17b11 Fbln2
3 B3galt6 Dmrt1 Fbln2 Dhh
4 Rps9 Sox9 Dhh Ndrg2
5 2010004m13rik Gm2a 2310046k01rik Ptn
6 Hemgn BC021891 Nr0b1/Dax1 Tpm2
7 Ndrg1 Etv5 4632411j06rik Stra6
8 Mmp23 Mmd2 Ifitm7 Thbd
9 Ptpre Fxyd6 Gas7 Myl1
10 Tnni3 Etv5 Mcm7 Scn5a
11 Inhbb Cyp26b1 Efhd1 Col6a2
12 Efhd2 Il6st Il6st LOC669875///Tspan15
13 Ermap Ecrg4 Dsp Adi1
14 Adamts8 Itm2a Bc019731 Adamts8
15 Lgals1 Fbln2 Gm2a Tpm2
16 Dmpk Dhh 1500015o10rik/Ecrg4 Aqp5
17 Hsd17b11 Bc019731 Mmd2 Gtl2
18 Eraf D3bwg0562e Cdon Dsp
19 Wnt11 Gpc3 2810026p18rik Gna14
20 Slc4a1 40787 Dusp26 Filip1
The twenty top-ranking genes showing significant down- or up-regulation (upper, A, vs lower half, B, of the table, resp.) in Foxl2-null ("KO") ovaries 
relative to wild-type and in various biological contexts. From left to right, top-ranking genes are given for the following conditions: ovaries lacking 
only Foxl2 (aged 13.5 dpc to birth); shared between newborn ovaries lacking Foxl2 and Kit and those lacking Foxl2 and Wnt4; shared by all three 
models (that all involve Foxl2 loss); and shared between embryo-fetal ovaries lacking Foxl2 and those lacking Wnt4 alone [Foxl2 ranks at the top 
because one or more of the conditions under analysis involve its ablation]. Genes known to be expressed in vasculature or germ cells are 
underlined, neuronal genes have an asterisk, and testis (lower, B) and other genes of interest (upper, A) are in bold font.BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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sented in Figure 3, along with others that involve
important novel candidate targets of Foxl2 (Clstn2, Grip1,
and Sgms2, see above). Arrows indicate gene dependencies
in terms of ranking by statistical significance in the micro-
array analyses; thus, the arrowhead points to gene(s) that
score among the top hits (i.e., for thick arrows, ranks 1
through 50) in the list of genes affected by the gene from
which the arrow originates. [Some gene dependencies that
have been shown to be strong in Rspo1-null ovaries, for
which microarray data are not available, are indicated
with blue arrows.] For example, Wnt4 and Emx2 scored
among the top hits in the respective lists of Emx2- and
Wnt4-dependent genes, respectively, consistent with pre-
vious reports [40,41]. Similarly, zona pellucida genes Zp2
and Zp3 were identified among the genes most strongly
down-regulated in the absence of Lhx8, Nobox and Figla.
In addition, thin and broken-line arrows indicate progres-
sively lower degrees of dependence (i.e., rankings arbitrar-
ily set at 50–150 and > 150, resp.); for instance,
intermediate (thin arrow) dependencies include that of
Dax1/Nr0b1 for Wnt4, a dependence that is known to be
only partial [47].
Overall, Figure 3 shows that in spite of a widespread net-
work of positive correlations among well-known ovarian
genes, they are affected to a different degree in distinct
pathological conditions, with a quite clear-cut separation
of the main candidate targets of somatic genes Emx2/
Rspo1/Wnt4/Foxl2 from those of oocyte genes Lhx8/Nobox/
Figla/Foxo3 (green/pink vs red boxes, resp., in Figure 3;
different colors are used for Foxl2 and Wnt4-related genes
because of their partial independence, see below). This is
consistent with the proposal that somatic cells and
oocytes may act on largely distinct though complemen-
tary pathways to promote ovary development. The rela-
tion of these genes to testis-like markers (blue boxes in
Figure 3) was more complex (see below).
We then extended the analysis from known markers to the
complete gene lists obtained by microarray profiling, and
thus determined their degree of overlap by chi-square
(Table 2 and see Methods). As expected, most lists were
positively correlated with one another (i.e., genes up- or
down-regulated in the absence of one ovarian gene tended
to change in the same direction in the absence of the others;
see additional files 6A–H). Nevertheless, one exceptional
trend was notable: the lists of genes that depend on Foxl2
and those dependent on Wnt4 or Emx2 were negatively cor-
related. In other words, genes that were up-regulated in the
absence of Wnt4 or Emx2 were preferentially down-regu-
lated in the absence of Foxl2, and vice versa (p < 0.001, chi-
square; see additional file 7). In particular, important devel-
opmental genes that were up in Foxl2-null ovaries and
down in Wnt4-null ovaries included known or likely Wnt4-
dependent genes in the ovary [Nr0b1/Dax1, Amhr2, and
Podxl; the last of which is also a candidate Wnt4 target in the
kidney (see additional file 7D and data not shown)].
These differences were reflected in the relative distribution
of several pathways listed in the Gene Ontology and
KEGG databases (at FDR 10%; Table 3 and see additional
file 8). In particular, glucose metabolism and protein syn-
thesis were strongly enriched in Foxl2-null ovaries but
depleted in Wnt4-null ovaries, respectively, whereas cell-
cell interactions and neuronal-like pathways were
depleted in Foxl2-null ovaries but enriched in the absence
of Wnt4. Consistent with reduced cell-cell signaling, loss
of Foxl2 apparently led to reduced cell migratory activities,
as inferred from the down-regulation of MAPK and several
cancer-related pathways that are presumably involved in
ovarian tissue remodeling, as well as apoptotic factors that
may have homeostatic actions in these processes. This is
consistent with the notion that Foxl2 is a critical determi-
nant of ovary histogenesis, notably follicle formation.
Putative interactions among developmental genes inferred  from the comparison of several knockout models of ovarian  dysgenesis Figure 3
Putative interactions among developmental genes 
inferred from the comparison of several knockout 
models of ovarian dysgenesis. Arrows indicate positive 
interactions. Most cases of competitive or antagonistic inter-
actions are not represented, because all genes except Sox9 
and Dhh can be connected by (positive) arrows with at least 
an ovarian gene. Sox9 and Dhh are not induced by any of the 
ovarian genes that have been functionally tested, and are 
antagonized specifically by Foxl2 and Wnt4. Color coding is 
purely indicative of overall gonadal expression and/or func-
tion (legend is at the bottom). Note that inferences regarding 
direct or indirect regulatory biochemical interactions cannot 
be derived from this type of analysis: arrows only indicate the 
apparent requirement of a gene (to which the arrow points) 
for the function of another gene (from which the arrow orig-
inates) as assessed in knockout mice. This identifies a puta-
tive target-regulator connection. Line thickness indicates the 
degree of statistical association between the putative target 
gene and the putative regulator.
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Of interest, Foxl2 loss also affected Wnt-signaling. Global
alterations associated with oocyte genes were much less
pronounced (none scored at the 10% FDR threshold).
Consistent with a complementary action of oocytes and
somatic cells, loss of oocyte genes led to a mixture of
Foxl2- and Wnt4-associated features (not shown).
The results thus support our previous findings that Foxl2
and Wnt4 act independently during ovary differentiation,
and further substantiate the notion that they may partly
antagonize each other and/or regulate mutually competi-
tive pathways. Nevertheless, some known gonadal genes
were top-ranking candidate targets of both Foxl2  and
Wnt4, including Kitl and Fst (pink-green color in Figure 3
and see additional file 1D). Novel genes of potential inter-
est that were strongly down-regulated in ovaries lacking
Foxl2 or Wnt4, and thus responsive to the sum of their
actions, included Gpc4 and Akr1c14 (see additional file 7A
and see Discussion). Additional hits included several tran-
scription factors, e.g., Msx1, Grip1, Tcf4, and Foxp1 (see
additional file 7A). Although they scored relatively low,
these genes were up-regulated in Foxl2-transgenic mouse
embryos (see below). Thus all of these genes, many of
them expressed in somatic cells, now become candidates
for a Foxl2-dependent role in coordinating ovarian his-
togenesis and/or steroidogenesis.
2.4. Anti-testis roles of Foxl2 and Wnt4, and of other possible 
regulatory genes
We next focused on genes that were significantly up-regu-
lated in ovaries lacking Foxl2 alone or in combination
with Kit or Wnt4. They included both ovarian and testis
genes. The ovarian genes included Nr0b1/Dax1, Wnt4 and
Rspo1 as well as novel candidates, such as Zbtb7c; the testis
genes included Sox9, Dhh, Dmrt1, and Cyp26b1 (Table 1,
Figure 2, and see additional file 3 and 6). It is notable that
these and other top-scoring ovarian and testis genes have
important roles in sex determination and/or early sexual
dimorphism (reviewed by, e.g., [18]). Thus, in the absence
of Foxl2, the exacerbation of Foxl2-independent ovarian
pathways(s) coincided with the partial de-repression of
testis-like genes. This started during embryonic develop-
ment, even in single knockout ovaries that are morpho-
logically normal until birth (see Discussion). Similarly,
and consistent with much earlier onset of morphological
anomalies, Wnt4-null single knockout ovaries showed de-
repression of some testis genes, e.g., Dhh and Inhbb; and
although Foxl2 was not up-regulated in these dysgenetic
ovaries by whole-organ microarray (see additional file 5),
its levels remained high compared to other ovarian genes
and were increased by real-time PCR (Figure 2, and see
below). In addition, FOXL2 protein expression was
strongly detected in the persisting cord-like and follicle-
like structures (data not shown).
The expression levels of some early testis-like genes
showed opposite directions of change in the absence of
distinct ovarian genes. In particular, Inhbb was up in fetal
ovaries lacking either Wnt4 or Foxl2, but down in ovaries
lacking the oocyte gene Lhx8 and in the most masculi-
nized phenotype that we have studied, i.e., Wnt4-/-Foxl2-/-
double knockout newborn ovaries (Figures 2 and 3). Sim-
ilarly, Robo1, which is up-regulated in Wnt4-null ovaries
([43] and see additional file 6B), showed reduced levels in
ovaries lacking Foxl2 (Figure 3 and see additional file 3A).
Therefore, regulation of these testis-like genes, and their
impact on the ovarian phenotype, may depend on the
conditional interactions of multiple ovarian factors.
Similar to loss of Foxl2 or Wnt4, loss of Lhx8 led to up-reg-
ulation of a few genes that are normally expressed in testes
(e.g., Stra6 see additional file 6F). However, this effect did
Table 2: Degree of concordance between lists of differentially expressed genes in several models of ovarian dysgenesis.
Emx2 KO Wnt4 KO Foxl2 KO
Concordant Discordant Concordant Discordant Concordant Discordant
Emx2 KO -- 1643 635 (716) (1292)
Wnt4 KO ---- ( 6 1 0 ) (1628)
Lhx8 KO 1295 789 1223 747 1491 452
Nobox KO 345 256 312 287 428 163
Foxo3 KO 500 346 396 347 530 257
Nobox KO Foxo3 KO Figla KO (*)
Concordant Discordant Concordant Discordant Concordant Discordant
Lhx8 KO 1166 86 764 495 69 5
Nobox KO -- 266 69 39 2
Foxo3 KO ---- 40 3
Concordance or discordance measured as the number of genes that showed the same or opposite directions of change pairwise comparisons of 
distinct knockout ("KO") models. The upper part of the table compares somatic genes among themselves and with oocyte genes, the lower part 
compares oocyte genes (the smaller list reported for Figla-null ovaries is indicated by *; see Methods). Bold font or underline indicate positive or 
negative correlations among lists, resp.BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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not extend to genes known to be involved in testis sex
determination, suggesting that Foxl2- and Wnt4-null ova-
ries are better suited to identify novel anti-testis genes.
To identify novel candidate anti-testis genes with a "mas-
ter" regulatory role comparable to Foxl2 or Wnt4, we used
a simple statistical approach (Methods) that detects genes
that are both testis-depleted and up- or partially down-
regulated in the dysgenetic ovary relative to the wild-type
ovary. The gene candidates for "independent anti-testis"
gene action in the Foxl2-null or Wnt4-null ovaries are
listed in additional files 9A–C, with the top-ranking hits
given in Table 4. As expected as an internal control, con-
sistent with their relative independence [17], Wnt4 was
top-ranking in Foxl2-null ovaries, and Foxl2 in Wnt4-null
ovaries. In addition, the overlap between the two lists
detected Rspo1 [21] and numerous oocyte genes as female-
enriched and independent of both Wnt4 and Foxl2 [the
latter may again reflect the overall independence of
oocytes from loss of either Wnt4 (before birth) or Foxl2].
In addition, several other genes were expressed in somatic
cells, i.e., Runx1, Irx3, a Foxl2-antisense transcript, Wnt9a,
and Zbtb7c. The relative levels of all of them were vali-
dated by multiple microarray probe sets and/or by real-
time PCR (as well as in studies of Foxl2 transgenic mice,
below). These genes may thus have a role in autonomous
pathways capable of antagonizing testis differentiation
independently of Foxl2 and Wnt4.
3. Foxl2 transgenic mice
We used Foxl2-transgenics to see if candidate Foxl2 targets
inferred from the microarray analyses presented above
were indeed responsive to Foxl2 (Figure 4A, B and 4C;
there the levels of individual genes are compared in
gonads from wild-type males, wild-type females, trans-
genic males, and transgenic females). As expected, Foxl2
Table 3: KEGG analysis on gene lists for Foxl2-null or Wnt4-null fetal ovaries.
Foxl2 null-depleted Foxl2 null-enriched
Pathway N Proportion N Proportion p-value
Ubiquitin mediated proteolysis (42) (0,06) 11 0,02 0,00003
Insulin signaling pathway (35) (0,05) 8 0,01 0,00004
ErbB signaling pathway (28) (0,04) 6 0,01 0,00018
MAPK signaling pathway (58) (0,09) 26 0,04 0,00067
Axon guidance (40) (0,06) 15 0,02 0,00132
Prostate cancer (22) (0,03) 5 0,01 0,00146
Colorectal cancer (27) (0,04) 8 0,01 0,00179
Long-term potentiation (19) (0,03) 4 0,01 0,00252
Adherens junction (24) (0,04) 7 0,01 0,0032
Glioma (19) (0,03) 5 0,01 0,00644
Apoptosis (15) (0,02) 3 0,00 0,0074
Wnt signaling pathway (41) (0,06) 19 0,03 0,00773
Alanine and aspartate metabolism 0 0,00 (8) (0,01) 0,00318
One carbon pool by folate 2 0,00 (13) (0,02) 0,00333
Glyoxylate and dicarboxylate metabolism 0 0,00 (9) (0,01) 0,00154
Glycolysis/Gluconeogenesis 3 0,00 (19) (0,03) 0,00035
Oxidative phosphorylation 7 0,01 (33) (0,05) 0,00001
Ribosome (protein synthesis) 3 0,00 (79) (0,13) 0
Wnt4 null-depleted Wnt4 null-enriched
Pathway N Proportion N Proportion p-value
Ribosome (protein synthesis) (55) (0,09) 70 , 0 1 0
Oxidative phosphorylation (51) (0,08) 70 , 0 1 0
Glycolysis/Gluconeogenesis (18) (0,03) 3 0,00 0,00008
Fructose and mannose metabolism (15) (0,02) 4 0,01 0,00194
Calcium signaling pathway 16 0,03 (45) (0,06) 0,00548
Neuroactive ligand-receptor interaction 19 0,03 (52) (0,07) 0,00441
Leukocyte transendothelial migration 9 0,01 (33) (0,04) 0,00396
Cell adhesion molecules (CAMs) 7 0,01 (31) (0,04) 0,00141
Cytokine-cytokine receptor interaction 18 0,03 (54) (0,07) 0,00135
Natural killer cell mediated cytotoxicity 9 0,01 (36) (0,05) 0,00115
Complement and coagulation cascades 2 0,00 (19) (0,02) 0,00131
ECM-receptor interaction 9 0,01 (37) (0,05) 0,00076
Focal adhesion 23 0,04 (70) (0,09) 0,00014
Columns from left to right: name of the pathway, number and proportion of genes that are down- or up-regulated in the respective knockout 
model, and corresponding p-value. All the pathways with FDR < 10% are shown. Underlines indicate pathways that are enriched in the 
corresponding columns.BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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expression was absent or at background levels in gonads
from XY wildtype embryos. But in XY transgenic embryos,
gonadal levels of Foxl2 were similar to wildtype ovaries,
and XX transgenic ovaries showed even stronger expres-
sion (nearly 2-fold, see additional file 10). This correlated
with sex-specific effects, as follows.
All female markers normally up-regulated during early
ovarian differentiation, whether sexually dimorphic or
not, were expressed at consistently higher levels in 13.5
dpc Foxl2-transgenic ovaries relative to wild-type litterma-
tes (21 genes tested, Figures 4B and 4C and see additional
file 11). That included Rspo1, Fst, Wnt4, Dax1/Nr0b1 and
Zbtb7c. In XX embryos, up-regulation overtly extended to
the meiotic markers Sycp3 and Dmc1h. The status of Foxl2
candidate targets inferred from the microarray analysis of
Foxl2 knockout mice is thereby validated, and there are
hints of feed-forward interactions with Foxl2-independent
genes, such as Wnt4, Rspo1 and Zbtb7c (see Discussion).
Furthermore, several ovarian genes were up-regulated to
various extents in 13.5 dpc transgenic XY gonads, which
contained severely disorganized seminiferous tubules
[17]. These changes are consistent with the induction of a
limited degree of male-to-female sex reversal in Foxl2
transgenics. Among the statistically significant genes were
some expressed in meiotic germ cells (Sycp3 and Dmc1h)
and others in somatic cells, i.e., Zbtb7c, Clstn2, Grip1,
Lrrc4 and aromatase (Cyp19a1). In particular, induction
of aromatase and Clstn2 in Foxl2 transgenic XY gonads was
remarkably strong relative to testes (Figure 4B). This is in
agreement with previous in vitro studies indicating that
Foxl2  can transactivate the aromatase promoter (e.g.,
[48,49]). Conversely, 13.5 dpc Foxl2-transgenic XY gonads
showed reduced expression of the male sex determining
genes Sox9 and Dhh. In addition, strong repression was
seen for downstream embryonic testis-specific genes of
endocrine relevance (e.g., the antimullerian hormone,
Amh, and Cyp11a1/P450ssc, which were reduced 3- and
18-fold, respectively). Repression was also strikingly pro-
nounced for the two male germ cell markers tested, Xmr
and Oct4, which were reduced 26- and 4-fold, respectively
(Figure 4A).
A few results were unanticipated; e.g., the Foxl2 transgene
down-regulated the expression of Wnt4 and Dax1/Nr0b1
Table 4: The thirty top-ranking genes for an action independent of Foxl2 and Wnt4.
Rank GeneId Gene Description
1 Xist Inactive × specific transcripts
2 Tspan33 Tetraspanin 33
3 Runx1 Runt related transcription factor 1
4 Kctd14 Potassium channel tetramerisation domain containing 14
5 Tktl1 Transketolase-like 1
6 Glt8d4 Glycosyltransferase 8 domain containing 4
7 Rspo1 R-spondin homolog (Xenopus laevis)
8 Foxl2os Foxl2os
9 Lrba LPS-responsive beige-like anchor
10 Irx3 Iroquois related homeobox 3 (Drosophila)
11 Sycp3 Synaptonemal complex protein 3
12 Podxl Podocalyxin-like
13 Smc1b Structural maintenance of chromosomes 1B
14 Fndc5 Fibronectin type III domain containing 5
15 2010004M13 RIKEN cDNA 2010004M13 gene
16 Gm1564 Gene model 1564, (NCBI)
17 Lzts1 Leucine zipper putative tumor suppressor 1
18 Taf7l TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor
19 1700007E06 RIKEN cDNA 1700007E06 gene
20 Zbtb7c Zinc finger and BTB domain containing 7C
21 Emx2 Empty spiracles homolog 2 (Drosophila)
22 Gdpd2 Glycerophosphodiester phosphodiesterase domain containing 2
23 Ndufa1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1
24 GM1140 Gene model 1140, (NCBI)
25 Lrrn1 Leucine rich repeat protein 1, neuronal
26 Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide
27 Fst Follistatin
28 Myh8 Myosin, heavy polypeptide 8, skeletal muscle, perinatal
29 Dmrtc1c Doublesex and mab-3 related domain, member 1C
30 Rgs2 Regulator of G-protein signaling 2
This list includes candidate genes for an autonomous anti-testis role relative to both Foxl2 and Wnt4.BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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while increasing expression of Inhbb. These unanticipated
effects may result from an exacerbation of the inferred par-
tial antagonism between Foxl2 and Wnt4, and possibly
relate to the complex responses shown by Inhbb attendant
on the loss of various ovary genes alone or in combina-
tion (see above). In any case, the preponderance of the
data provide independent support for an early anti-testis
action of Foxl2 – whether by delaying development of XY
gonads or by promoting male-to-female sex reversal. Most
important, the Foxl2-mediated disruptive effects, includ-
ing the suppression of Wnt4, were confined to XY
embryos. The notion of a specific and early sexually
dimorphic role for Foxl2 is thereby supported.
4. Gene dosage effects in Foxl2+/- heterozygous ovaries
Loss of a single copy of Foxl2 might represent a model for
the heterozygous FOXL2 mutations that affect patients.
We looked at the extent to which heterozygotes expressed
molecular anomalies like those seen in Foxl2-null ovaries.
We focused on two stages, 16.5 dpc and 7 dpn (days post-
natum), because the corresponding Foxl2-null ovaries
showed well-differentiated morphological states that were
either normal or well engaged in abnormal development.
In order to identify molecular anomalies associated with
heterozygous loss of function, we generated oocyte- vs
somatic cell gene lists enriched in fetal vs postnatal ovaries
of heterozygous mice. The lists were based on published
microarray data, supplemented by a list of the probes for
known testis determining genes (Methods and see addi-
tional file 12). We then evaluated differential enrichment
in these lists by a sensitive algorithm that detects non-ran-
dom distributions in pair-wise comparisons (Gene Set
Enrichment Analysis, or GSEA, [50]; all these results are
presented in additional file 13; see Methods).
We first tested testis-determining genes (including Dmrt1,
Sox9, Dhh, Fgf9, and Sf1/Nr5a1), which, as a group, were
significantly up-regulated in 16.5 dpc Foxl2+/-  hetero-
zygous ovaries relative to wild-type (p < 0.03, GSEA), with
levels that were comparable to those in Foxl2-null ovaries
(p = 0.20, GSEA). These findings raise the possibility that
loss of a single allele of Foxl2 may be sufficient for a signif-
icant though weak derepression of testis genes in the fetal
mouse ovary. Nevertheless, this effect appeared to be tran-
sient. Indeed, in 7 dpn Foxl2+/- heterozygous ovaries, the
microarrays evinced no significant trend toward the
expression of testis markers (p > 0.2, GSEA). This con-
trasted with Foxl2-null ovaries, which, consistent with our
previous studies showing delayed postnatal oocyte
growth and partial sex reversal (see above), showed a sig-
nificant enrichment of testis determining genes at 7 dpn
(p = 0.02, GSEA).
Consistent with ongoing sex reversal, 7 dpn Foxl2-null
ovaries also showed a sharp extensive repression of post-
natal oocyte and somatic follicle cell markers compared to
both  Foxl2+/- heterozygous and wild-type ovaries (p <
0.001, GSEA). Compared to Foxl2-null ovaries, Foxl2+/-
heterozygous ovaries exhibited normal expression of
oocyte growth genes but showed clear dosage effects for
somatic follicle markers. The latter were inhibited almost
as much in heterozygotic ovaries as in Foxl2-null ovaries
compared to wild-type (p < 0.001, GSEA). Furthermore,
as expected for a dosage-related response, the inhibition
in heterozygous ovaries was less strong than in Foxl2-null
ovaries (p < 0.001). Top-scoring genes were often known
or likely to be involved in early steps of follicle growth,
Expression levels of several gonadal genes in 13.5 dpc gonads  from Foxl2 transgenic embryos compared to littermates Figure 4
Expression levels of several gonadal genes in 13.5 dpc 
gonads from Foxl2 transgenic embryos compared to 
littermates. A: genes known for a role in early testis differ-
entiation, some of which are also expressed in the adult 
ovary; B: novel or known ovarian genes that are induced by 
Foxl2 in XY and XX gonads; C: novel or known ovarian genes 
that are induced by Foxl2 in XX but not XY gonads.
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i.e., Inhba, Inhbb, Cyp11a1/P450ssc, Cyp17a1, Nr5a2 (see
additional file 14), as well as novel genes with a likely role
in somatic cells, e.g., Odz4 (see above). Several of these
genes are known to be involved in steroidogenesis. Thus,
in the absence of one Foxl2 allele, strong dosage effects in
somatic follicle growth genes contrasted sharply with the
normal expression of oocyte growth genes.
In addition, in 16.5 dpc and 7 dpn Foxl2+/- heterozygous
ovaries, we found significant up-regulation of markers for
fetal  ovary development, independent of whether they
were germline- or somatic cell-enriched (e.g. Figla, Sohlh1,
Sycp3, vs Rspo1, Irx3, Gng13, p < 0.001 and p < 0.01, resp.,
GSEA). This suggests that Foxl2+/- heterozygous ovaries
undergo a developmental delay starting in fetal life.
Discussion
We have analyzed mouse ovary development and matura-
tion based on comparative gene expression profiling of
wild-type stages and pathological conditions. First, we used
an unsupervised clustering algorithm, PCA, to show that
gonadal developmental genes can discriminate stages of
ovarian differentiation and maturation throughout life.
However, sexual dimorphism was resolved only partly, i.e.,
conditional on developmental time. Thus, as a second,
supervised approach, we focused on Foxl2-null ovaries.
Cellular models are currently lacking for both sex determi-
nation and follicle formation. Whole-organ studies pro-
vide an alternative route to investigate underlying
developmental processes, which involve complex interac-
tions of cell types. However, whole-organ studies are par-
ticularly sensitive to biological confounds such as overt
changes in cell-type composition. To circumvent such
effects, we compared conditions that were associated with
highly divergent ovarian phenotypes but shared a com-
mon genotype, i.e., loss of Foxl2 or Wnt4 alone or Foxl2 in
combination with Kit  or  Wnt4  (Section 2.2). Indeed,
largely distinct cell types are affected in the null ovaries
that lack Foxl2, Kit or Wnt4 (i.e., somatic supporting cells,
germ cells, and stroma cells, resp.). It is thus unlikely that
secondary and conditional targets of Foxl2 would be sim-
ilarly affected by chance in the very different phenotypes
associated with these three models of ovarian dysgenesis.
Thus, the lists resulting from a series of distinct dysgenetic
ovary models involving loss of Foxl2 should be enriched
in primary targets of this gene. Similar considerations led
us to search for common putative targets of Foxl2 and
Wnt4, as their deletion induces somewhat complemen-
tary phenotypes (Section 2.3). The analysis enables us to
suggest novel genetic interactions and ovarian genes that
are either candidate targets or act independently of Foxl2
and Wnt4. Results were validates by Foxl2 overexpression
studies and the analysis was extended to Foxl2+/- heterozy-
gotes (Sections 2.4–4).
The data lead to four main inferences.
1) Partial convergence of somatic transcriptomes in 
maturing ovary and testis
One inference from the present analysis is that by unsu-
pervised principal component analysis (PCA), meiotic
activity and some testis-related pathways (which include
genes such as Dhh and Cyp11a1) may be dissociated from
other pathways that include follicle formation (which
include Lhx8 and Figla), as they map along two different
axes (PC1 vs PC2). This suggests that two major pathways,
one more closely related to germ cell differentiation and
the other to somatic cell histogenesis, may act autono-
mously during gonadal development. This is consistent
with some current theories on the mechanisms of sexual
dimorphism; but the range of autonomous (groups of)
pathways may be greater than two, as indicated by our
supervised analyses (see below)
A second inference from PCA is that a large fraction of the
mouse ovarian developmental transcriptome becomes
progressively similar to testis after birth. As shown in Fig-
ure 1A, PCA discriminates fetal and newborn ovaries from
wild-type adult gonads, which cluster with fetal-newborn
testes along PC1. This supports accumulating evidence for
a link between ovary maturation and a predisposition of
this organ to form testis-like tissues [16]. We found that
the shift toward testes was accelerated in several knockout
or mutant ovary models compared to age-matched wild-
type ovaries (Figure 1B). However, PCA did not discrimi-
nate between contributions to this pattern from the loss of
meiotic activity or from the activation of testis-like path-
ways expressed in somatic cells. In addition, some critical
gonadal genes correlated only poorly with PCA coordi-
nates. Foxl2 and Sox9 were notable examples. PCA failed
to detect their standing as the current best markers for
wild-type female and male supporting cells, exemplified
by their striking pattern of mutually exclusive expression
in a wide range of different conditions involving partial
sex-reversal [14,17,51]. Rather than conferring variable
degrees of predisposition to sex reversal, Foxl2 and Sox9
seem to act as all-or-none switches, and their mutual
antagonism may be determinative in sex determination
[16]. We further tested this proposal by supervised analy-
ses of the Foxl2-null ovary transcriptome.
2) Specific gene candidate targets of Foxl2 and 
comparison of ovaries lacking Foxl2 vs other early ovarian 
factors
By comparing single and compound knockout ovaries
lacking Foxl2, we have identified and ranked 149 candi-
date genes for a specific role downstream of Foxl2 (top
gene list in Table 1, second column from right, and see
additional file 4 for the full list). KEGG pathway analysis
indicated that in Foxl2-null fetal ovaries, neuronal-likeBMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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pathways, migratory activity and cell-cell interactions
were reduced, whereas glucose metabolism and protein
synthesis were increased (Table 3 and see additional file
8). Of note, Wnt4-null ovaries showed a largely inverse
metabolic profile, and we observed a significant negative
correlation between the inferred candidate target genes of
Wnt4 and Foxl2 (Table 2 and Figure 3). This contrasts with
results when several other ovarian genes are ablated.
Those mouse models show largely positive correlations,
though the strength of dependence of the shared candi-
date targets varies, notably between somatic genes and
oocyte genes (Table 2 and Figure 3; see Results). Thus, the
widely divergent molecular anomalies observed in Wnt4
and Foxl2-null fetal ovaries provide an entry point to the
mechanisms underlying the partly autonomous, comple-
mentary roles of these genes in ovary development.
Consistent with KEGG results, several genes that are
known to be expressed by neurons and vascular cells in
other systems, e.g., Calstn2, Odz4 and Lrrc4, were among
the most sensitive candidate Foxl2 targets (Table 1). In
addition, some steroidogenesis-related genes (Grip1 and
Akr1c14) were also affected very early by loss of Foxl2. This
early effect is striking considering that in the mouse ovary,
active steroidogenesis occurs postnatally. Steroidogenesis
is completely repressed in postnatal Foxl2-null mouse
ovaries [26] and steroidogenic genes are strongly affected
in  Foxl2  transgenic mouse embryos (discussed below).
Some additional Foxl2-dependent genes, expressed in
both somatic cells and oocytes, may be associated with
novel ovarian functions, including Sgms2 and Bicd1 (see
Results).
Comparison of the positive candidate targets shared by
Foxl2 and Wnt4 pointed to additional genes that may inte-
grate the outputs of the respective largely independent
pathways (Table 1 and see additional file 8). They include
the genes encoding the well-known Kit ligand, KITL, the
Wnt4-effector Follistatin, the proteoglycan GPC4, and sev-
eral other candidate genes for novel roles in ovary devel-
opment, i.e., Msx1, Grip1, Tcf4, and Foxp1  (bold
characters, Table 1; see additional file 8A–D and Figure 4).
All of these genes, many of them expressed in somatic
cells, are enriched in fetal wild-type ovaries compared to
testis and become candidates for a role in coordinating
ovarian histogenesis and/or steroidogenesis.
Novel ovarian candidate target genes that we inferred to
be positively regulated by Foxl2 from the comparison of
single and double knockout mice were assessed in Foxl2
transgenic embryos. All were up-regulated in XX gonads,
with occasional, limited upregulation in XY gonads as
well (N = 21; Figures 5B and 5C and see additional file 7).
These findings confirm the ability of the microarray anal-
ysis to detect bona fide targets of Foxl2, independent of
whether Foxl2 regulatory action is direct or indirect. The
great majority of these genes had been missed in previous
less complete in vitro microarray studies (e.g., [52]. In par-
ticular, we found limited overlap between the differen-
tially expressed gene lists (121 of 1192 of the genes
detected in vitro were identified in vivo). The expectation
that genes up-regulated by Foxl2 in vitro would likely be
down-regulated in the Foxl2-null ovaries (positive candi-
date targets), and vice-versa (negative candidate targets),
was met only to some extent (p = 0.10, chi-square). Nev-
ertheless, the overlapping hits included several biologi-
cally validated or promising genes, e.g., Nr5a2, Zbtb7c,
Mmp23 and Inhbb (see additional file 15). In short, even
though in vitro data included a plethora of hits that appear
unrelated to the in vivo situation, some genes that overlap
do have known or putatively important roles in vivo. This
suggests that in vitro models may provide useful informa-
tion in the study of gonadal development, though exten-
sive filtering by comparison to in vivo data is required.
Overall, our Foxl2 transgenic model shows a generalized
induction of ovary markers in XX embryos and a severe
perturbation of testis markers in XY embryos, underlining
a sex-specific action of Foxl2. The strongest effects of the
Foxl2 transgene in XY embryonic gonads involved male
germ cell genes and sexually dimorphic steroidogenic fac-
tors [the reduction of Xmr, Oct4 and P450ssc/Cyp11a1 to
baseline levels and the strong upregulation of aromatase/
Cyp19a1 as well as other ovarian genes, e.g., Clstn2, Lrrc4,
and Zbtb7c, Figure 4]. Nevertheless, the earliest gonadal
defects involving sex reveral that are observed in female
steroidogenesis-deficient mice (i.e., lacking aromatase- or
both estrogen receptors) occur around the time of puberty
(e.g., reviewed by [16]). Thus, aromatase and estrogen
action can only partly account for Foxl2 action, and pre-
sumably only at later stages during ovary development
and maturation. The early branches of the Foxl2 pathway
remain to be characterized more fully.
3) Early embryonic action of Foxl2
A striking result from the microarray analysis is the early
time at which Foxl2-null ovaries showed significant anom-
alies, i.e., by 13.5 dpc, the time at which germ cells com-
mit to the oocyte fate in mice. Some ovarian genes
(candidate positive targets of Foxl2) were down-regulated
and some ovarian and testis-like genes were consistently
up-regulated (Figure 2 and see additional file 5). Thus,
Foxl2-null ovaries show subtle features of partial sex
reversal starting during early embryonic development.
Nevertheless, levels of testis genes were low in prenatal
Foxl2-null mouse ovaries (i.e., they increased by only 7–
30% of the difference between testes and baseline signal
in wild-type ovaries, by real-time quantitative PCR, Figure
2). This may explain why we previously failed to detect
SOX9 protein expression at these stages [14]. In any case,BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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the early, reproducible transcriptional dysregulation of a
number of testis and ovarian genes suggests that the
female sex determination program is partly impaired in
embryonic ovaries that lack Foxl2. These subtle alterations
may predispose to overt molecular sex reversal, which
occurs postnatally in the supporting cell lineage of Foxl2-
null ovaries, and is accelerated and extends to all other cell
types in ovaries lacking both Wnt4 and Foxl2 (see Intro-
duction). The data also suggest widespread antagonistic or
competitive interactions between Foxl2 and Wnt4 during
fetal development (see Results).
The molecular anomalies detected in Foxl2-/- single knock-
out ovaries occur earlier than the earliest time of onset of
histological sex reversal reported in mouse models so far
(late fetal life in an Rspo1-null model and in the Wnt4-/-
Foxl2-/- double knock-out ovaries we have studied [17,21]
and data not shown). Instead, RSPO1  mutations and
Foxl2 downregulation in humans and goats, respectively,
are associated with much earlier, nearly complete forms of
female-to-male sex reversal [27,28].
To reconcile differences among species, one possibility
infers that other genes, possibly expressed in oocytes
[15,53], may be involved in female sex determination,
and some might well be mouse-specific. Alternatively, as
we have previously suggested, several autonomous ovar-
ian gene pathways conjointly repress testis differentiation,
but their autonomy may be more pronounced in mice
than in higher mammals [16,17].
We infer several candidate anti-testis genes that are
expressed independently of both Foxl2 and Wnt4 by com-
paring gene expression patterns associated with the partial
ovary-to-testis sex reversal (as observed in the correspond-
ing single gene knockout models) to both testis and wild-
type ovary profiles. Some of these candidate anti-testis
genes have been partially characterized previously – e.g.,
Wnt9a and Irx3 (cf. [21,54]), whereas others are novel,
e.g.,  Zbtb7c  (Table 4). Their function should become
clearer with ablation studies to determine their interac-
tions, with particular attention to any dependence on
Rspo1 [21]. Genes with restricted gonadal expression also
become candidates for possible involvement, via constitu-
tive mutations, in human patients affected by non-syn-
dromic forms of 46, XX sex reversal or premature ovarian
failure.
4) Dosage effects in Foxl2-/+ heterozygotes
A fourth inference from the analyses is that anomalies in
Foxl2+/- heterozygous ovaries were milder but similar to
Foxl2-null ovaries. They included reduced expression of
follicle genes, notably involved in steroidogenesis, and
the transient coexpression of some fetal ovary and testis
genes at levels higher than normal. These features suggest
that loss of one Foxl2 allele might decrease the stability of
ovary sex determination, and might possibly be impli-
cated in the etiology of premature ovarian failure in heter-
ozygous FOXL2+/- human patients [25].
Conclusion
The connection between the mechanisms of follicle for-
mation and female reproductive competence in mammals
has long been appreciated [3], but an involvement of
embryonic anti-testis genes has only recently been sug-
gested. Among the known anti-testis genes, Foxl2 has a
special status because it is required in supporting cells
throughout ovarian development ([14,17] and this
study), and its continuous expression in postnatal primor-
dial follicles suggests a possible role in the maintenance of
female reproductive capacity [16]. However, the compre-
hensive analysis of available microarrays adds to the
weight of evidence that additional gene pathways that
may have a more limited action in time, independently
promote ovarian differentiation and repress the alterna-
tive testis fate. They include at least one pathway involving
Rspo1 and Wnt4 as well as novel candidate factors ([42]
and see above). The identification of the full range of inde-
pendent anti-testis genes and their most specific targets, as
inferred from appropriate series of partly overlapping
combinations of mutant genotypes, now becomes a focus
for further investigation.
Methods
Mouse strains and RNAs
We previously reported the generation of mice lacking
Foxl2 alone or in combination with Wnt4-null or KitWv
hypomorphic alleles, as well as mice expressing a Foxl2
transgene [17,26]. For newborn and postnatal ovaries
processed with Agilent microarrays (see below), strains
were a mixed background from 129S6/SvEvTac and NIH-
Swiss/BC. For 15.5 dpc Wnt4-null single knockout ovaries
and the respective age-matched controls [47], they were a
mixture of C57BL/6J and the original 129 strain. For all
other ovaries processed with Affymetrix microarrays, mice
were a mixture of C57BL/6J, NIH-Swiss/BC and CD1.
RNA samples for each genotype and developmental stage
were obtained from gonads of individual mice (biological
replicates), and were processed as follows.
RNA extraction of the samples and microarray platforms
For the Affymetrix platform, total RNA was extracted with
the MELT enzymatic system (Ambion) followed by purifi-
cation and linear amplification with the Pico Ovation kit
(Nugen). For the Agilent Platform, total RNA was
extracted by mechanical homogeneization and purified
on RNeasy affinity columns.
For the Affymetrix MOE430 v.2 platform, all gonadal
samples were assayed on three biological replicates,BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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except for Wnt4-null mice and their age-matched controls
collected at 15.5 dpc, which were studied in duplicate
(that is, two mice each). Gonads from individual mice
served as biological replicates; thus controls were compa-
rable to the small numbers of double-knockout mice that
were available, limited in numbers by high prenatal mor-
tality. A step of RNA amplification was thus required.
Foxl2-null ovaries and wild-type littermates were collected
at 13.5 dpc, 16.5 dpc and on the day of birth (18 sam-
ples). Ovaries from newborn mice lacking Foxl2  and
Wnt4, or Foxl2 and Kit, were compared to age-matched
controls lacking Wnt4 or Kit but harboring a wild-type
Foxl2 allele (12 samples). Testis samples were collected at
13.5 dpc and at birth. The latter were from Wnt4-null
mice, which show partly defective testis differentiation.
This was done in order to facilitate the assessment of the
degree of sex reversal affecting newborn ovaries lacking
both Wnt4 and Foxl2 [17].
The microarray analysis of the Foxl2 gene dosage effects
was performed on Foxl2-null, Foxl2+/- heterozygous and
wild-type ovaries that were obtained in triplicate at 16.5
dpc (9 samples) or in duplicate from pools of 4–8 mice at
7 days postnatum (dpn) (4 samples). The 16.5 dpc ovary
samples were hybridized on the Affymetrix MOE430 v.2
platform after RNA amplificatioon (see above), whereas
the 7 dpn ovaries were assayed on the Agilent 44 k mouse
developmental platform without RNA amplification.
Additional Foxl2-null and wild-type newborn ovaries were
processed in triplicate and analyzed on the Agilent plat-
form, mainly for cross-platform validation purposes (see
below). All our microarray datasets can be downloaded
from the public web site, http://www.ncbi.nlm.nih.gov/
geo, via the accession number GSE12989.
Microarray data normalization
Raw Affymetrix data (.CEL) file processing and normaliza-
tion was performed by the plier program in R (at cran.r-
project.org) with an additional step of scaling to the glo-
bal mean.
For data from the 44 k mouse developmental array from Agi-
lent, after background subtraction from the Agilent analyzer
raw output data, calculation of the ratio of the channels was
followed by normalization of each sample values against a
virtual microarray dataset by local mean regression as imple-
mented by the loess program on R (span 0.01). The reference
virtual dataset contained the average expression values for
each probe across all samples.
Additional available microarray datasets (available at 
http://www.ncbi.nlm.nih.gov/geo or http://www.ebi.ac.uk/
microarray-as/ae/)
Datasets for models of (whole-organ) gonadal dysgenesis
that we have accessed from the public domain are from four
distinct laboratories, as follows: Emx2-/- (GSE10216),Lhx8-/-
(GSE7774),  Nobox-/-  (GSE7775),  Foxo3-/-  (GSE8249) and
Wnt4-/- kidney (GSE6934) ([42,44] and unpublished data).
We processed the raw data (Affymetrix MOE430 v.2 CEL
files) with plier on R. Normalized datasets were directly used
for PCA or analyzed to obtain lists of genes that were differ-
entially expressed in mutant vs control ovaries with the
Focus software [30]. We thus selected the hits corresponding
to a minimum Focus score of 4 under bootstrap-optimized
FDR (see below), with the exception of the Foxo3-/- samples.
For those only a handful of genes were obtained with the
same procedure. This was consistent with the inability of a
published study to identify any differentially expressed genes
at birth in these datasets [44]. Therefore, for the Foxo3-/- sam-
ples, we raised the Focus score threshold for probe selection
to 6 but used no FDR; we reason that the degree of concord-
ance between the resulting gene lists and several other gene
knockout models (see Results) validated the procedure. Fur-
thermore, a strong correlation was obtained between the
gene lists obtained from the Foxo3-/- newborn ovaries and
those from 7 dpn ovaries, which could be investigated with
or without optimized FDR (p = 0.001; not shown). This indi-
cates that in spite of the lack of the FDR control, the Foxo3-/-
newborn ovary gene lists were enriched in specific though
possibly indirect targets of Foxo3. They were thus included in
comparisons with the other prenatal and newborn ovary
models (see Results). Gene lists for Wnt4-/- and Figla-/- ova-
ries, which were obtained with different microarray plat-
forms, were taken from the respective reports without
modification [43,45].
The datasets involving only wild-type whole-organ
gonadal samples were as follows: normal ovary and testis
development from 11.5 dpc to 2 dpn (GSE5334 and
GSE4818) and from 11.5 to 18.5 dpc (GSE6916) from
two distinct laboratories ([55] and unpublished data),
and one adult ovary and testis each (as well as Kitl hypo-
morphic adult testis) from two other laboratories
(GSE8249 and GSE1986, [44] and unpublished data).
One dataset was for oocytes from primordial through
antral follicles (GSE3351, [37]). We used that dataset to
infer lists of oocyte genes showing decreasing vs increas-
ing expression profiles from early through growing folli-
cles with Focus (as above), thus inferring genes expressed
in fetal vs. growing oocytes, as given additional file 12. In
order to obtain somatic cell-enriched genes, we subtracted
the corresponding oocyte gene lists from the lists associ-
ated with parallel expression profiles (i.e., decreasing vs
increasing, resp.) in whole-organ ovaries aged 0 through
14 dpn (GSE8249, [44]). This produced the lists of genes
enriched in fetal vs postnatal somatic cells, in additional
file 12.
Additional published microarrays on purified cells were
as follows: Sf1/Nr5a1:GFP from ovaries and testes agedBMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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10.5 through 13.5 dpc (E-MEXP-454, [38]) or 10.5–11.5
dpc (GSE3463, [56]), as well as Sry:GFP-positive support-
ing somatic cells aged 13.5 dpc (GSE4928, [57]). We also
reanalysed a Wnt4-/- newborn kidney microarray that was
deposited but is not accompanied by publication
(GSE6288).
Principal component analysis
Several approaches are available to identify markers of
biological interest from microarray data. Completely
unsupervised approaches, which do not incorporate
information on class identity, perform less well than their
supervised counterparts, which instead use such informa-
tion explicitly. Supervised algorithms include recent ver-
sions of discriminant analysis (such as "prediction
analysis of microarray, PAM, [29]). The design thus favors
the identification of the most strongly class-discrimina-
tory biomarkers. However, it is not clear how the resulting
informative biomarkers, besides their role in the output
classifier, might be related to one another. In addition, the
identification is vulnerable to any bias resulting from a
priori definition of the classes. Therefore, a mixed unsu-
pervised-supervised approach may represent a better solu-
tion.
Principal component analysis (PCA) is an unsupervised
method for clustering and classification that, contrary to
other unsupervised algorithms (such as hierarchical or k-
means clustering), incorporates a statistical description of
the datasets. In general, the purpose of PCA is to rotate
data points into a new coordinate system, such that the
majority of the variance in the data is distributed along
the directions of a subset of the new axes. This facilitates
visualization of significant patterns or trajectories within
the data. In addition, the resulting axes are uncorrelated.
Thus, each axis can represent the activity of clusters of
genes showing a specific pattern (i.e., positively or nega-
tively correlated expression patterns), or linear combina-
tions thereof, and each pattern is uncorrelated to the
others, thus possibly representing an independent biolog-
ical process. PCA has its own drawbacks (e.g., interpreta-
tion of axes representing complex combinations of
patterns of covariation may be challenging, and axes asso-
ciated with small amounts of variance may be spurious).
However, it can identify the major uncorrelated trends of
variation in the data and quantify their contribution to
the total variance.
Mixed unsupervised-supervised approaches to PCA have
been proposed that restrict the dataset to the genes that
may be considered more informative for a biological proc-
ess of interest, by other statistical methods [58,59]. The
resulting approach, which might be termed "calibrated
PCA" (because no explicit information on predefined
classes is provided), was found to perform as well as as the
best fully supervised classification algorithms that are cur-
rently available [59]. Furthermore, the approach retains
the ability, which is inherent in PCA, to reveal any addi-
tional unpredicted patterns that may exist within and
among the known classes, thus reducing the effect of any
biases at the step of class selection.
Based on these considerations, we used a general
approach defining minimal "classes" as the known bio-
logical conditions, i.e., the set of replicates that were avail-
able for each combination of genotype and
developmental stage under study. We obtained the lists of
genes that showed the highest level of variation across
such predefined classes using the Focus software ([30],
setting the standard cutoff at Focus score 4; see below) and
carried out standard PCA on the values for such genes in
the samples of interest.
By carrying out PCA on the samples taken from all exper-
iments simultaneously, the first principal components
(i.e., the PCA axes accounting for the maximum variation)
distinguished the experiments more than they discrimi-
nated the biological conditions; this result was obtained
on rank-normalized values – that is, in spite of the use of
a procedure that could help to reduce laboratory-related
bias [60]. Therefore, we restricted PCA to the samples
from each single experiment (the training dataset), lead-
ing to a PCA space onto which the samples from the other
experiments (the test datasets) were mapped (i.e., classi-
fied). Mapping the test dataset involved the "pseudo-
inverse matrix" method computed with the svd function
in R [59]. To further reduce the effect of experimental idi-
osyncrasies, we obtained the developmental marker list
from one dataset and trained the PCA on a distinct data-
set. In particular, we used, in turn, each of the three largest
developmental series available on whole-organ gonadal
samples, as well as the largest dataset on somatic cells
from embyonic gonads (GSE5334 and GSE4818;
GSE6916; our own dataset GSE12989; and E-MEXP-454,
resp., and see above). The combination of marker list and
training dataset that gave the best resolution (i.e., involv-
ing the genes that were most variable across GSE5334 and
GSE4818 samples as the marker list, with our dataset as
the training dataset) is discussed in the main text and is
reproduced in Figures 1A and 1B; further information is
given in additional file 1A and 1B. The corresponding
marker list is given in additional file 2B, along with a rep-
resentative shorter list that showed a comparable discrim-
inative power (at the cutoff that retained the 300 top
ranking variable markers, see additional file 2A and data
not shown).
We obtained the lists of genes that were most significantly
associated with PC1 and PC2 of the selected PCA (see
above) by dividing each PC into three equal segmentsBMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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between the minimum and maximum values along the
coordinates, thus defining 3 classes that contained the
samples mapping within the corresponding coordinates.
We then used the Focus program to rank genes by the
extent to which their expression levels increased
or decreased through these classes (see additional files
2B–C).
Detection and ranking of differentially expressed genes
In all cases, we applied the Focus software [30] to the
entire microarray datasets, i.e., without any pre-filtering of
the probes. Focus ranks genes according to the statistical
distribution of contrasts (i.e., sums of weighted means)
calculated as the linear transformation of four parameters
(ratios and differences of expression intensities between
conditions, as well as their consistency within each condi-
tion). The weights were chosen to represent arbitrary
directions of change (such as, 1 and 0 in pair-wise com-
parisons, or 0, 1 and 2 in three-way comparisons). These
values were then normalized according to the distribution
of the replicates among the distinct conditions, as imple-
mented in Focus. We used the bootstrap algorithm imple-
mented in Focus to select hits that were associated with at
least 1.1-fold mean differences, scored higher than the
default "interest score" threshold of 4 and correspond-
ingly to an "optimized" threshold value of the false dis-
covery rate (FDR). The Focus interest score reflects the
statistical distance of each probe from the mean of the
probes' distribution in terms of the combined standard
deviations of the four Focus parameters presented above.
The bootstrap-based algorithm selects an FDR cut-off in
order to simultaneously minimize the estimated propor-
tion of false negative errors, as inferred from the observed
t-test distribution of the expression values [30].
The combination of a fold-ratio with an optimized FDR is
intermediate between the procedures that combine a fold-
ratio with either a fixed FDR or a fixed p-value cut-off (the
former is widely used but may be too stringent, the latter
was recommended by the Microarray Quality Control
Consortium [61]). In addition, as can be inferred from the
gene lists produced for Foxl2-null newborn ovaries vs con-
trols analyzed with Affymetrix versus Agilent platforms,
we found that using an optimal FDR led to greater specif-
icity (i.e., a greater fraction of consistent hits) and
increased sensitivity (i.e., a larger number of total hits)
than the alternative methods (not shown).
In order to detect genes that were significantly associated
with the Foxl2-null or Wnt4-null ovary phenotypes, we
included our wild-type and heterozygous ovary samples
from all developmental stages that can be considered,
phenotypically, as normal controls (see additional files
3A–B and 7A–B). This was done with the purpose of span-
ning the range of variation that we had observed for the
normal gonadal transcriptome by PCA (see above). As a
complementary approach, we also identified the genes
that were shared by the three pair-wise comparisons of
age-matched Foxl2-null and wild-type ovaries from 13.5
dpc through birth (see additional file 3C).
Gene Ontology and KEGG analysis
We obtained the KEGG (Kyoto Encyclopedia of Genes
and Genomes) and Gene Ontology classification for
mouse genes from the mmu00001.keg database at
ftp.genome.jp and the "GO" libraries available at http://
www.affymetrix.com and, for Agilent probes, at http://
www.bioconductor.org (GOENTREZID2GO function in
the GO package); the analyses were performed in R
(scripts available on request). The lists of differentially
expressed genes between Foxl2- or Wnt4-null knockout
ovaries and wild-type controls (above) were tested for any
significantly different distribution across KEGG catego-
ries, i.e., by a comparing pairwise proportions using Fisher
exact tests; we set a false discovery rate (FDR) threshold of
10% (see additional file 8). Similar results were obtained
with GO (not shown).
Identification of candidate genes for a role independent of 
Foxl2 and Wnt4
We identified the genes that showed the geatest variation
according to the following profile: Wnt4- or Foxl2-null
ovary > wild-type ovary > testis. For this analysis, we thus
included our embryonic and testis samples in the analyses
of the single knockout ovaries described above. Linear
contrasts implemented in Focus helped to emphasize
directions of change rather than strict pattern similarity.
This three-way comparison has the advantage of reducing,
in the comparison between knockout and wild-type ova-
ries, the relevance of both the magnitude and the sign of
any differences or direction of change, as long as these dif-
ferences were statistically small relative to the difference
between ovary and testis. Because the mutant and wild-
type ovaries were chosen to be morphologically and his-
tologically closer to one another (e.g., before oocyte loss
occurred in some models) than either was to testis, the
risk of selecting idiosyncratic features of the mutants (e.g.
Wnt4- or Foxl2-null ovary >> wild-type ovary ~testis) was
expected to be low. Thus, genes were ranked according to
how strongly they maintained or exacerbated a wild-type
ovary-like activity relative to testis (see additional files
9A–B, combined -by boolean intersection- into additional
file 9C; the top 30 genes from additional file 9C are given
in Table 2).
Real-time PCR
Using real-time PCR (TaqMan, Applied Biosystems), we
assayed the same samples that were processed for the
microarrays as well as additional biological samples,
employing at least three biological replicates per condition.BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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Gonads from Foxl2 transgenic 13.5 dpc embryos were also
collected and compared to their wild-type littermates, fol-
lowing a heat-shock treatment to activate the transgene as
previously reported [17]. Normalization was performed by
scaling to expression values of the succinyl dehydrogenase
A subunit, Sdha. Consistent results were obtained by using
another gene as the scaling factor, Gapdh. Real-time PCR for
validation of the microarray data involved the following
genes (and TaqMan probes): Amh (Mm00431795_g1),
Apcdd1 (Mm01257559_m1), Apoa1 (Mm00437569_
m1), Aromatase (Mm00484049_m1), Asb9
(Mm00518372_m1), Bax (Mm00432050_m1), Bicd1
(Mm00802208_m1), Ccdc113 (Mm00556701_m1), Clgn
(Mm00515517_m1), Cyp26b1 (Mm00558507_m1),
Dax1 (Mm00431729_m1), Dhh (Mm00432820_g1),
Dmrt1 (Mm00443809_m1), Dmrt3 (Mm00616649_m1),
Figla1 (Mm00488823_m1), Foxl2 (Mm00843544_s1), Fst
(Mm00514982_m1), Gdf9 (Mm00433565_m1), Gdnf
(Mm00599849_m1), Inhbb (Mm03023992_m1), Kcnd2
(Mm00498065_m1), Mid1lip1 (Mm00471535_m1),
Mmp15 (Mm00485062_m1), Mmp23 (mm00488768_
m1), Nedd9 (Mm00479569_m1), Nr5a2 (Mm00446088_
m1), Odz4 (Mm00446088_m1), P450ssc (Mm004907
35_m1), Pcdh11x (Mm01221603_m1), Plzf (Mm011768
68_m1), Ptdgs (Mm01330613_m1), Rspo1 (Mm005070
77_m1), Sgms2 (Mm00512327_m1), Sox9 (Mm00448
840_m1), Sycp3 (Mm00488519_m1), Wnt4(ex1–2)
(Mm01194003_m1), Xmr (Mm00784689_s1), Zbtb7c
(Mm00520231_m1). All results were consistent with the
microarray data, with the partial exception for Mid1lip1
and Pcdh11x (Figure 2 and data not shown). The latter may
correspond to alternative isoforms differentially recognized
by microarray vs PCR assays.
Real-time PCR for the study of embryonic gonads from
the transgenic mice (Figure 4 and additional file 11)
involved the following genes (and TaqMan probes):
Akrc14 (Mm00506336_m1), Amh (Mm00431795_g1),
Clstn2 (Mm00502574_m1), Cyp19a1 (Mm004840
49_m1), Dax1 (Mm00431729_m1), Dhh (Mm004328
20_g1), Dmc1h (Mm00494485_m1), Foxp1 (Mm00
474845_m1), Fst (Mm00514982_m1), Gpc4 (Mm00
515035_m1), Grip1 (Mm00503844_m1), Inhbb (Mm03
023992_m1), Kitl (Mm00442972_m1), Lrrc4 (Mm025
27970_s1), Mllt1 (Mm00452080_m1), Msx1 (Mm0044
0330_m1), Oct4 (Mm00658129_gH), Odz4 (Mm004
96266_m1), P450ssc (Mm00490735_m1), Plx nc1
(Mm00450687_m1), Rspo1 (Mm00507077_m1), Sgms2
(Mm00512327_m1), Sox9 (Mm00448840_m1), Sycp3
(Mm00488519_m1), Tcf4 (Mm00443198_m1), Wnt4
(Mm01194003_m1), Xmr (Mm00784689_s1), Zbtb7c
(Mm00520231_m1).
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Additional material
Additional file 1
The PCA plot from main text Figure 2 (x-axis: PC1; y-axis: PC2) in 
which the gonadal samples are coded to highlight additional features. 
A) distinct colored symbols and shapes indicate distinct experimental 
source (detailed next), sex, genotype, and developmental stage (detailed 
in the margins). "E" indicates embryonic day; "P" indicates postnatal day. 
B) color coding now is for the datasets of origin; distinct colors thus repre-
sent distinct experiments performed by different laboratories (with the 
number of samples per dataset that is given in brackets; see Methods). 
Shape-coding, as in A.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S1.pdf]
Additional file 2
Developmental markers for the PCA, thus including all the markers 
identified as significant by Focus analysis. The list in A (top 6455 
probes) was used for the main figures; the lists of the genes that were most 
significantly associated with the first and second principal components 
(PC1 and PC2) are given in B and C, resp.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S2.xls]
Additional file 3
Genes that were down- (A, C) or up-regulated (B, D) in Foxl2-null 
ovaries aged 13.5 dpc through birth compared to age-matched con-
trols. Scores (second column from left) are standard deviations of four 
parameters for differential expression obtained with the Focus program 
(see text). A-B: overall ("multiwise") comparison of three developmental 
stages using linear contrasts with Focus (i.e., 6 genotype × stage condi-
tions). C-D: overlap of the gene lists obtained by three separate pairwise 
analyses each confined to age-matched conditions (i.e., each developmen-
tal stage was analyzed separately; Focus scores were averaged over the 
three analyses).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S3.xls]
Additional file 4
Genes that are consistently down- (C) or up- (D) regulated in all 
three pathological conditions involving Foxl2 loss that we have tested. 
A-B. Genes that are down- or up- regulated (A-B, resp.) in double knock-
out ovaries lacking Foxl2 and either Wnt4 or Kit relative to controls. C-
D: genes shared between such two models of double knockout ovaries and 
the ovaries lacking Foxl2 alone (from additional files 3A–B).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S4.xls]BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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Additional file 5
Microarray gene expression profiles of the genes that were assayed by 
real-time PCR in Main Figure 2. For each gene, normalized expression 
intensities (y-axis) are represented as a fraction of the maximum mean 
value observed (the latter being set to 100).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S5.pdf]
Additional file 6
Genes that were differentially expressed in single knockout ovaries 
lacking genes different from Foxl2. A-B, genes that were down- or up-
regulated in Wnt4-null ovaries aged 15.5 dpc relative to controls aged 
13.5 dpc through birth. C-J, genes that were down- (C, E, G, I) or up- 
(D, F, H, J) regulated in Lhx8- (C, D), Nobox- (E, F), Foxo3-null (G, 
H) newborn ovaries or Emx2-/- (I, J) 10.5 dpc bipotential gonads relative 
to age-matched controls.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S6.xls]
Additional file 7
Overlap between the lists of Foxl2- or Wnt4-dependent genes. A, 
downregulated, B, upregulated in both single knockout ovaries relative to 
controls, as determined from additional files 3A–B and 6C–D.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S7.xls]
Additional file 8
KEGG classification of the gene lists relevant to Table 3. The gene lists 
are derived from additional files 3A–B (down and up in Foxl2-null fetal 
ovaries or in Wnt4-null fetal ovaries relative to wild-type controls (from 
additional files 3A–B and 6A–B). A-B, Foxl2-null ovaries vs wild-type; 
C-D, Wnt4-null ovaries vs wild-type. All KEGG categories with p-value 
less than 0.1 by Fisher exact test (comparison of proportions) are included. 
Columns from left to right: Pathway name, numbers of genes for the 
knockout and for the wild-type ovaries, p-value, proportions for the knock-
out and for the wild-type ovaries, and finally two standard gene identifi-
cations. The 10% FDR threshold p-value is 0.0077 for A-B, and 0.0054 
for C-D.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S8.xls]
Additional file 9
Lists of anti-testis genes that were inferred to have an action inde-
pendent of Foxl2 (A), Wnt4 (B) or both (C). comparison of knockout 
ovaries to both ovary and testis (see text for details on the approach).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S9.xls]
Additional file 10
Real-time PCR showing Foxl2 transcript levels in Foxl2 transgenic 
mouse embryonic gonads. XX or XY trangenic embryos were compared to 
wildtype littermates.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S10.pdf]
Additional file 11
Real-time PCR validation in Foxl2 transgenic mouse embryos and 
wildtype littermates. This panel includes Foxl2-dependent genes (based 
on knockout models, see text) that are induced at higher levels in Foxl2 
transgenic XX gonads and are either weakly induced (Plxnc1, Tcf4, 
Odz4) or not induced (Gpc4, Foxp1, Mllt3, Akr1c14) in Foxl2 trans-
genic XY gonads.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S11.pdf]
Additional file 12
Oocyte and somatic cell-enriched gene lists represented by the corre-
sponding probes in the Affymetrix MOE430 v.2 (A) and Agilent 
mouse developmental (B) platforms. These lists were used for GSEA 
analysis presented in additional file 13. They correspond to the top-scoring 
hits from additional microarray analyses (see text) with an arbitrary cut-
off at the 50th or 100th rank (labeled as "Top50" and "Top100"). Addi-
tional labels (see Methods for details): OvFetSoma, enriched in fetal ovary 
somatic cells relative to bipotential gonad and to testis (Sf1-positive cells); 
FetalOo, enriched in newborn oocytes relative to postnatal growing 
oocytes; OoGrow, enriched in postnatal growing oocytes relative to new-
born oocytes; SomaGrow, enriched in postnatal growing somatic cells by 
an indirect analysis, i.e., enriched in postnatal versus newborn whole-
organ ovary preparation and excluded from the "OoGrow" markers; "tes-
tis determination markers", genes known to be involved in gonadal XY sex 
reversal when inactivated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S12.xls]
Additional file 13
GSEA plots for the study of Foxl2-gene dosage effects. Any deviation 
from random of the distribution of 9 lists of marker genes given in addi-
tional file 12 is tested between the following conditions. Labels at the top 
of each panel correspond to the acronyms that denote the lists of additional 
file 12. A blue-red gradient along the x-axis indicates increasing differen-
tial expression toward either condition under comparison. Values for the 
relevant statistical parameter are shown on the y-axis by a green line. 
Thus, the highest vs lowest peak of this curve relative to a horizontal black 
line (baseline) provide estimates for the degree of enrichment toward 
either the "red" or the "blue" condition, respectively. A, Foxl2-null 
(E16ko, red) vs Foxl2+/- heterozygous ovaries at E16.5 dpc (E16het, 
blue); B, E16het (red) vs Foxl2+/+ wild-type ovaries at E16.5 dpc (E16wt, 
blue); C, E16ko (blue) vs E16wt (red); D, Foxl2-null (P7ko, red) vs 
Foxl2+/- ovaries at 7 dpn (P7het, blue); E, P7het (red) vs Foxl2+/+ wild-
type ovaries at 7 dpn (P7wt, blue); F, P7ko (red) vs P7wt (blue).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S13.pdf]
Additional file 14
Representative gene expression levels (microarray) that illustrate 
Foxl2-gene dosage effects in newborn (P0) or 7 dpn ovaries (P7). Top 
panel: somatic cell genes; bottom panel: oocyte genes. Note that P7 heter-
ozygous ovaries (2nd group of bars from right) express high levels of oocyte 
genes and low levels of somatic genes compared to age-matched wild-type 
ovaries (right-most group of bars).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-36-S14.pdf]BMC Developmental Biology 2009, 9:36 http://www.biomedcentral.com/1471-213X/9/36
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